Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Synergy CHC Corp SNYR

Synergy CHC Corp. is a consumer healthcare and beauty company. The Company is a portfolio of consumer health care and beauty brands, including FOCUS factor, FLAT TUMMY CO, HAND MD, Sneaky Vaunt, THE QUEEN PEGASUS. FOCUS factor is a brain health supplement brand. FLAT TUMMY CO is a lifestyle brand, which helps women achieve their nutrition and weight management goals. HAND MD is a hand care brand to maintain clean, healthy and beautiful hands. THE QUEEN PEGASUS provides eyelash serum for longer and thicker looking natural lashes. Sneaky Vaunt offers flat tummy tea.


GREY:SNYR - Post by User

Post by stockfyon Nov 22, 2017 5:00am
80 Views
Post# 27009224

Case study: LOOP's 100% (uplisting) and SNYR's uplisting

Case study: LOOP's 100% (uplisting) and SNYR's uplisting Another case study regarding how the uplisting from OTC to NYSE or Nasdaq boosts market awareness and usually makes the stock double in 3-6 months.

See Loop Industries and Loop Industries' performance during the last 5 months.

Loop was LLPP on the OTCBB and uplisted to Nasdaq two days ago under the ticker LOOP.

See its chart on the OTCBB when it was LLPP.

LLPP was at $7.50 in May 2017 and LOOP closed at $15.10 on the Nasdaq.

This is a 100% return in 5 months.


With $7 million adjusted EBITDA in 2017 and at least  $8 million adjusted EBITDA in 2018, SNYR is grossly undervalued compared to the peer group and SNYR will at least double in 2018 once uplisting is completed.

<< Previous
Bullboard Posts
Next >>